ABERRANT JAK/STAT SIGNALING IN CUTANEOUS T CELL LYMPHOMA
ABERRANT JAK/STAT SIGNALING IN CUTANEOUS T CELL LYMPHOMA
批准号:
6633889
负责人:
MARIUSZ A. WASIK
金额:
$24.96万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2006-02-28
关键词:
JAK kinase Retroviridae antisense nucleic acid clinical research cytokine receptors enzyme activity enzyme inhibitors gel mobility shift assay human subject immunocytochemistry interleukin 15 interleukin 2 interleukin 4 interleukin 7 interleukin 9 methyltransferase mycosis fungoides lymphoma neoplastic process oligonucleotides protein tyrosine phosphatase tissue /cell culture transcription factor transfection /expression vector transport proteins
中文摘要
描述:(摘自申请者的摘要)本研究的目的是
明确异常细胞因子信号转导的作用和机制
在人皮肤T细胞淋巴瘤(CTCL)的发生和发展中起重要作用。
它将集中在与JAK/STAT相关的信号通路在CTCL中的作用
细胞因子受体共同的Y链(YC)由几个受体共享
受细胞因子的刺激,这些细胞因子对细胞的激活和成熟至关重要
正常T细胞:IL-2、-4、-7、-9和-15。我们的初步数据显示
YC相关的Jak/STAT通路在CTCL细胞中被激活。而在
不太晚期(低级别/低阶段)的CTCL病例出现这种激活
细胞因子诱导,在较晚期(中级/高级/高级阶段)
情况是构成的,至少部分原因是缺乏负面的
调节通常由SHP-1磷酸酶介导。在这项研究中,我们将
详细研究其在恶性细胞中的表达、功能状态和作用
JAK/STAT信号转导通路的转化
这一途径的抑制剂(SHP-1磷酸酶、PIAS和SOCS蛋白)
培养的新鲜CTCL细胞。我们会特别注意
惰性(低)的JAK/STAT通路的功能差异
等级/低阶段)和攻击性(中级/高等级/高阶段)类型
CTCL。在懒惰的CTCL中,将进行实验以确定
YC信号细胞因子对水母细胞的生长和存活至关重要。
恶性T细胞。
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) The purpose of this study is
to define the role and understand the mechanisms of aberrant cytokine signaling
in the pathogenesis and progression of human cutaneous T-cell lymphoma (CTCL).
It will focus on the role in CTCL of the Jak/STAT signaling pathway associated
with the cytokine receptor common y chain (yc) shared by several receptor
stimulated by cytokines which are critical for activation and maturation of
normal T cells: lL-2, -4, -7, -9, and -15. Our preliminary data indicate that
the yc-associated Jak/STAT pathway is activated in CTCL cells. Whereas in the
less advanced (low grade/low stage) cases of CTCL this activation appears
cytokine induced, in the more advanced (intermediate/high grade/high stage)
cases it is constitutive and at least in part due to the lack of negative
regulation normally mediated by a SHP-1 phosphatase. In this study we will
examine in detail the expression, functional status, and role in malignant cell
transformation of the Jak/STAT signal transduction pathway as well as
inhibitors of this pathway (SHP-1 phosphatase and PIAS and SOCS proteins) using
cultured and fresh CTCL cells. Particular attention will be paid to the
differences in functioning of the Jak/STAT pathway between the indolent (low
grade/low stage) and aggressive (intermediate/high grade/high stage) types of
CTCL. In the indolent CTCL, experiments will be performed to determine which of
the yc-signaling cytokines is (are) critical for growth and survival of the
malignant T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(m) TOR signaling in EBV-associated lymphomas
-
批准号:7093171
-
项目类别:
-
资助金额:$27.09万
-
财政年份:2005
-
负责人:MARIUSZ A. WASIK
-
依托单位:
(m) TOR signaling in EBV-associated lymphomas
-
批准号:7231674
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2005
-
负责人:MARIUSZ A. WASIK
-
依托单位:
(m) TOR signaling in EBV-associated lymphomas
-
批准号:7075814
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2005
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Dysregulation of STAT3 in ALK-induced oncogenesis
-
批准号:7086206
-
项目类别:
-
资助金额:$29.41万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Novel role of STAT3 in NPM/ALK-induced oncogenesis
-
批准号:7989123
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Novel role of STAT3 in NPM/ALK-induced oncogenesis
-
批准号:7744684
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Novel role of STAT3 in NPM/ALK-induced oncogenesis
-
批准号:8204454
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Dysregulation of STAT3 in ALK-induced oncogenesis
-
批准号:6914189
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Dysregulation of STAT3 in ALK-induced oncogenesis
-
批准号:6521647
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Novel role of STAT3 in NPM/ALK-induced oncogenesis
-
批准号:7591433
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Novel role of STAT3 in NPM/ALK-induced oncogenesis
-
批准号:8390441
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Dysregulation of STAT3 in ALK-induced oncogenesis
-
批准号:6604201
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Dysregulation of STAT3 in ALK-induced oncogenesis
-
批准号:6771822
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2002
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Jak/STAT signaling in human T-cell lymphomas
-
批准号:7212519
-
项目类别:
-
资助金额:$25.66万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Jak/STAT signaling in human T-cell lymphomas
-
批准号:7477661
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Jak/STAT signaling in human T-cell lymphomas
-
批准号:7906752
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
ABERRANT JAK/STAT SIGNALING IN CUTANEOUS T CELL LYMPHOMA
-
批准号:6860159
-
项目类别:
-
资助金额:$24.96万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
ABERRANT JAK/STAT SIGNALING IN CUTANEOUS T CELL LYMPHOMA
-
批准号:6228819
-
项目类别:
-
资助金额:$24.96万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Jak/STAT signaling in human T-cell lymphomas
-
批准号:7290974
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位:
Jak/STAT signaling in human T-cell lymphomas
-
批准号:7667221
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2001
-
负责人:MARIUSZ A. WASIK
-
依托单位: